收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 49.94B | 7.13% |
| Investment and other income | revenue | 407.00M | 6.54% |
| Earnings from operations | profit | 1.86B | 21.32% |
| Total operating expenses | cost | 48.08B | 6.65% |
| Aggregate | revenue | 2.27B | 18.37% |
| Medical costs | cost | 38.30B | 4.93% |
| Premium tax expense | cost | 5.38B | 27.60% |
| Selling, general and administrative expenses | cost | 3.40B | 1.31% |
| Cost of services | cost | 702.00M | 0.57% |
| Amortization of acquired intangible assets | cost | 166.00M | -4.05% |
| Depreciation expense | cost | 134.00M | -5.63% |
| Earnings before income tax | profit | 2.10B | 20.22% |
| Interest expense, nonoperating | cost | 164.00M | -3.53% |
| Debt extinguishment | revenue | 5.00M | |
| Net income (loss) attributable to noncontrolling interest | cost | 2.00M | -33.33% |
| Net earnings | profit | 1.54B | 17.12% |
| Income tax expense | cost | 560.00M | 29.63% |
| Earnings attributable to centene corporation | profit | 1.54B | 17.54% |
| Segment | Value | YoY |
|---|---|---|
| Medicaid | 28.89B | 9.29% |
| Medicare | 10.33B | 17.89% |
| Commercial | 9.56B | -5.84% |
| Other Operating | 1.18B | -8.19% |
| Segment | Value | YoY |
|---|---|---|
| Health Care, Premium | 43.89B | 5.21% |
| Service | 768.00M | -1.16% |
| Others | 5.29B | 28.03% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalent | assets | 21.26B | |
| Premium and trade receivables | assets | 19.43B | |
| Short-term investments | assets | 2.48B | |
| Other assets, current | assets | 1.82B | |
| Total current assets | assets | 44.99B | |
| Long-term investments | assets | 16.60B | |
| Goodwill | assets | 10.84B | |
| Intangible assets, net | assets | 4.36B | |
| Property, software and equipment, net | assets | 2.09B | |
| Restricted deposits | assets | 1.43B | |
| Other long-term assets | assets | 866.00M | |
| Total assets | assets | 81.17B | |
| Total liabilities | liabilities | 59.65B | |
| Total stockholders' equity | liabilities | 21.50B | |
| Redeemable noncontrolling interests | liabilities | 25.00M | |
| Total current liabilities | liabilities | 40.05B | |
| Long-term debt | liabilities | 16.31B | |
| Other long-term liabilities | liabilities | 2.55B | |
| Deferred tax liability | liabilities | 744.00M | |
| Equity, attributable to noncontrolling interest | liabilities | 75.00M | |
| Treasury stock, common, value | equity | 9.44B | |
| Accumulated other comprehensive (loss) | equity | 171.00M | |
| Total centene stockholders' equity | equity | 21.43B | |
| Medical claims liability | liabilities | 20.63B | |
| Accounts payable and accrued expenses | liabilities | 16.83B | |
| Return of premium payable | liabilities | 1.57B | |
| Unearned revenue | liabilities | 953.00M | |
| Current portion of long-term debt | liabilities | 63.00M | |
| Aggregate | equity | 31.04B | |
| Additional paid-in capital | equity | 20.82B | |
| Retained earnings | equity | 10.21B | |
| Common stock, $0.001 par value; authorized 800,000 shares; 625,477 issued and 493,771 outstanding at march 31, 2026, and 623,463 issued and 491,757 outstanding at december 31, 2025 | equity | 1.00M |
| Item | Value |
|---|---|
| Increase (decrease) in accounts payable and accrued liabilities | 2.90B |
| Net earnings | 1.54B |
| Other long-term liabilities | 849.00M |
| Depreciation and amortization | 300.00M |
| Unearned revenue | 217.00M |
| Medical claims liabilities | 95.00M |
| Share-based payment arrangement, noncash expense | 67.00M |
| Gain (loss) on extinguishment of debt | 5.00M |
| Other operating activities, net | -17.00M |
| Deferred income taxes | -53.00M |
| Increase (decrease) in other operating assets | -188.00M |
| Increase (decrease) in premiums receivable | -1.35B |
| Item | Value |
|---|---|
| Sales and maturities of investments | 1.28B |
| Payments to acquire property, plant, and equipment | -200.00M |
| Payments to acquire investments | -987.00M |
| Item | Value |
|---|---|
| Proceeds from common stock issuances | 10.00M |
| Other financing activities, net | 2.00M |
| Payments for repurchase of common stock | -29.00M |
| Repayments of long-term debt | -1.05B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 17.96B |
| Cash and cash equivalents, end of period | 21.35B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图,与现金流量表瀑布图,一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持